Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Eli Lilly · Phase 2 · Recruiting · Enrollment 1481

NCT06143956

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
LY3305677 Obesity ISA OXA1n/rn/rn/rn/r
LY3841136 Obesity ISA LAA1n/rn/rn/rn/r
LY3841136 Obesity ISA LAA2n/rn/rn/rn/r
LY3549492 Obesity ISA GN01n/rn/rn/rn/r
LY3549492 Obesity ISA GN02n/rn/rn/rn/r
Obesity ISA MC01n/rn/rn/rn/r

Not shown

  • LY3305677 Obesity ISA OXA1: endpoint not reported
  • LY3841136 Obesity ISA LAA1: endpoint not reported
  • LY3841136 Obesity ISA LAA2: endpoint not reported
  • LY3549492 Obesity ISA GN01: endpoint not reported
  • LY3549492 Obesity ISA GN02: endpoint not reported
  • Obesity ISA MC01: endpoint not reported